The investigation found that drug companies aggressively raise prices to meet revenue targets, that drug companies targeted the U.S. market for higher prices than are set in other countries, and that drug companies were engaged in anti-competitive practices to keep prices high.
Raskin discusses findings on drug pricing and anti-competitive practices by pharmaceutical companies.
Share
More from Jamie Raskin
President Trump is obviously desperate for the American people to ‘love’ him.
But stealing taxpayer dollars to pay for Mr. Trump’s narcissistic ego trips is plainly illegal.
The American people are apparently paying for Donald Trump to create desperate preelection propaganda.
Amidst an alarming increase in antisemitism, Islamophobia and other forms of toxic hate, Team Maryland is surging more than $8.6 million in federal Nonprofit Security Grants to protect our people.
Other voices in this conversation
